BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 38115780)

  • 21. Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
    Gordon PA; Winer JB; Hoogendijk JE; Choy EH
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD003643. PubMed ID: 22895935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Animal models in myositis.
    Katsumata Y; Ascherman DP
    Curr Opin Rheumatol; 2008 Nov; 20(6):681-5. PubMed ID: 18946328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inflammatory myopathies: evaluation and management.
    Greenberg SA
    Semin Neurol; 2008 Apr; 28(2):241-9. PubMed ID: 18351525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymyositis and dermatomyositis: Disease spectrum and classification.
    Raychaudhuri SP; Mitra A
    Indian J Dermatol; 2012 Sep; 57(5):366-70. PubMed ID: 23112356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammatory and toxic myopathies.
    Dalakas MC
    Curr Opin Neurol Neurosurg; 1992 Oct; 5(5):645-54. PubMed ID: 1327303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoantibodies to DNA mismatch repair enzymes in polymyositis/dermatomyositis and other autoimmune diseases: a possible marker of favorable prognosis.
    Muro Y; Nakashima R; Hosono Y; Sugiura K; Mimori T; Akiyama M
    Arthritis Rheumatol; 2014 Dec; 66(12):3457-62. PubMed ID: 25186186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymyositis/dermatomyositis associated with dermatitis herpetiformis.
    Kalovidouris AE; Miller FW; Lawley TJ
    Arthritis Rheum; 1989 Sep; 32(9):1179-81. PubMed ID: 2789048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis.
    Ceribelli A; Isailovic N; De Santis M; Generali E; Fredi M; Cavazzana I; Franceschini F; Cantarini L; Satoh M; Selmi C
    Clin Rheumatol; 2017 Feb; 36(2):469-475. PubMed ID: 27761751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Idiopathic inflammatory myopathies.
    Amato AA; Barohn RJ
    Neurol Clin; 1997 Aug; 15(3):615-48. PubMed ID: 9227956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymyositis Presenting With Nontraumatic Rhabdomyolysis and Dysphagia: A Case Report.
    Aldrete J; Peterson CJ; Tarbox JA; Pixley JS
    J Investig Med High Impact Case Rep; 2022; 10():23247096221074589. PubMed ID: 35264047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapeutic strategy in inflammatory myopathies (polymyositis, dermatomyositis, overlap myositis, and immune-mediated necrotizing myopathy)].
    Tournadre A
    Rev Med Interne; 2014 Jul; 35(7):466-71. PubMed ID: 24144868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The co-existence of myasthenia gravis in patients with myositis: a case series.
    Paik JJ; Corse AM; Mammen AL
    Semin Arthritis Rheum; 2014 Jun; 43(6):792-6. PubMed ID: 24412588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inclusion body myositis: a chronic persistent mumps myositis?
    Chou SM
    Hum Pathol; 1986 Aug; 17(8):765-77. PubMed ID: 3015764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rituximab in the treatment of inflammatory myopathies: a review.
    Fasano S; Gordon P; Hajji R; Loyo E; Isenberg DA
    Rheumatology (Oxford); 2017 Jan; 56(1):26-36. PubMed ID: 27121778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymyositis, dermatomyositis, and autoimmune necrotizing myopathy: clinical features.
    Khan S; Christopher-Stine L
    Rheum Dis Clin North Am; 2011 May; 37(2):143-58, v. PubMed ID: 21444016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical profile of anti-NXP-2 antibody-positive inflammatory myositis and outcome in an Indian population.
    Manwatkar A; Padiyar S; Nair A; Jha A; Kumar S; Yadav B; Prakash JAJ; Das JK; Mathew J
    Clin Rheumatol; 2023 Dec; 42(12):3289-3297. PubMed ID: 37801141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Immune Response and the Pathogenesis of Idiopathic Inflammatory Myositis: a Critical Review.
    Ceribelli A; De Santis M; Isailovic N; Gershwin ME; Selmi C
    Clin Rev Allergy Immunol; 2017 Feb; 52(1):58-70. PubMed ID: 26780034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Idiopathic myositis].
    Burgunder JM
    Ther Umsch; 2003 Jul; 60(7):407-12. PubMed ID: 12956034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology of Idiopathic Inflammatory Myopathies in Africa: A Contemporary Systematic Review.
    Essouma M; Noubiap JJ; Singwe-Ngandeu M; Hachulla E
    J Clin Rheumatol; 2022 Mar; 28(2):e552-e562. PubMed ID: 33843773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Idiopathic inflammatory myopathies: a review.
    Ashton C; Paramalingam S; Stevenson B; Brusch A; Needham M
    Intern Med J; 2021 Jun; 51(6):845-852. PubMed ID: 34155760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.